ORBIMED ADVISORS LLC – Global Blood Therapeutics, Inc. Transaction History
ORBIMED ADVISORS LLC portfolio value:
$0
portfolio value
ORBIMED ADVISORS LLC quarter portfolio value change:
+113.15%
quarter
Global Blood Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -100.00% | -2.04M shares | -65.30M | $68.1 | 0 |
| Q2 2022 | call | Decrease | -100.00% | -50K shares | -1.73M | $31.95 | 0 |
| Q2 2022 | share | Increase | +29.65% | 467.4K shares | 10.69M | $31.95 | 2.04M |
| Q1 2022 | call | Increase | 0.00% | 50K shares | 1.73M | $34.64 | 50K |
| Q1 2022 | share | Increase | 0.00% | 1.57M shares | 54.61M | $34.64 | 1.57M |
| Q4 2018 | share | Decrease | -100.00% | -309.5K shares | -11.76M | $41.05 | 0 |
| Q3 2018 | share | Decrease | -30.80% | -137.77K shares | -8.45M | $38 | 309.5K |
| Q2 2018 | share | Decrease | -69.50% | -1.01M shares | -50.61M | $45.2 | 447.27K |
| Q1 2018 | share | Decrease | -32.03% | -691.2K shares | -14.07M | $48.3 | 1.46M |
| Q4 2017 | share | Decrease | -9.86% | -235.90K shares | 10.58M | $39.35 | 2.15M |
| Q3 2017 | share | Increase | +10.21% | 221.7K shares | 14.92M | $31.05 | 2.39M |
| Q2 2017 | share | Increase | +100.27% | 1.08M shares | 19.43M | $27.35 | 2.17M |
| Q1 2017 | share | Increase | 0.00% | 1.08M shares | 39.96M | $36.85 | 1.08M |